文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

一种本地优化的数据驱动工具预测ICU脓毒症相关血管升压药使用

A Locally Optimized Data-Driven Tool to Predict Sepsis-Associated Vasopressor Use in the ICU.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论域适应改进脓毒症血管升压药预测模型外部验证性能,4小时AUC从0.77升至0.81。

开发点测试集预测4-24小时血管升压药使用的AUC为0.80-0.81,特异度56.2%-61.8%,阳性预测值5.6%-12.1%。

要点

  • 开发点测试集模型预测4-24小时血管升压药使用AUC为0.80-0.81,特异度56.2%-61.8%,阳性预测值5.6%-12.1%。
  • 适用人群为ICU成人脓毒症患者,排除从未发生脓毒症、ICU停留<8小时或>20天、入ICU前4小时内出现休克者。

适用人群与场景

  • 两家学术医学中心ICU收治的成人脓毒症患者,符合Center for Medicare and Medicaid Services严重脓毒症定义(入住ICU前或期间发生)。
  • 排除从未发生脓毒症、ICU停留时间<8小时或>20天、入ICU前4小时内出现休克的患者。

诊断标准与关键阈值

  • 脓毒症诊断依据Center for Medicare and Medicaid Services严重脓毒症定义。
  • 模型预测未来4-24小时血管升压药使用,开发点测试集AUC 0.80-0.81,验证点域适应后4小时AUC 0.81。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 观察性队列研究,纳入两家学术医学中心2014年1月至2017年6月共14,512例ICU脓毒症患者(开发点9,423例,验证点5,089例)。
  • 开发点测试集预测4-24小时血管升压药使用AUC 0.80-0.81,特异度56.2%-61.8%,阳性预测值5.6%-12.1%。

证据类型、等级与局限

  • 观察性队列研究,非随机对照试验,证据等级未提及。
  • 局限:回顾性数据,模型需外部验证,阳性预测值较低(开发点5.6%-12.1%,验证点8.9%),域适应方法需进一步前瞻性验证。

对床旁实践的改变

  • 该模型可提前4-24小时预测ICU脓毒症患者血管升压药需求,域适应可改善跨医疗系统外部性能,但阳性预测值较低,需结合临床判断。
  • 适用人群为符合CMS严重脓毒症定义的ICU成人患者,不适用于入ICU前4小时内已出现休克者。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To train a model to predict vasopressor use in ICU patients with sepsis and optimize external performance across hospital systems using domain adaptation, a transfer learning approach.

DESIGN: Observational cohort study.

SETTING: Two academic medical centers from January 2014 to June 2017.

PATIENTS: Data were analyzed from 14,512 patients (9,423 at the development site and 5,089 at the validation site) who were admitted to an ICU and met Center for Medicare and Medicaid Services definition of severe sepsis either before or during the ICU stay. Patients were excluded if they never developed sepsis, if the ICU length of stay was less than 8 hours or more than 20 days or if they developed shock up to the first 4 hours of ICU admission.

MEASUREMENTS AND MAIN RESULTS: Forty retrospectively collected features from the electronic medical records of adult ICU patients at the development site (four hospitals) were used as inputs for a neural network Weibull-Cox survival model to derive a prediction tool for future need of vasopressors. Domain adaptation updated parameters to optimize model performance in the validation site (two hospitals), a different healthcare system over 2,000 miles away. The cohorts at both sites were randomly split into training and testing sets (80% and 20%, respectively). When applied to the test set in the development site, the model predicted vasopressor use 4-24 hours in advance with an area under the receiver operator characteristic curve, specificity, and positive predictive value ranging from 0.80 to 0.81, 56.2% to 61.8%, and 5.6% to 12.1%, respectively. Domain adaptation improved performance of the model to predict vasopressor use within 4 hours at the validation site (area under the receiver operator characteristic curve 0.81 [CI, 0.80-0.81] from 0.77 [CI, 0.76-0.77], p < 0.01; specificity 59.7% [CI, 58.9-62.5%] from 49.9% [CI, 49.5-50.7%], p < 0.01; positive predictive value 8.9% [CI, 8.5-9.4%] from 7.3 [7.1-7.4%], p < 0.01).

CONCLUSIONS: Domain adaptation improved performance of a model predicting sepsis-associated vasopressor use during external validation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Holder AL, Shashikumar SP, Wardi G, et al. A Locally Optimized Data-Driven Tool to Predict Sepsis-Associated Vasopressor Use in the ICU. Crit Care Med. 2021. PMID: 34259450. doi:10.1097/CCM.0000000000005175

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。